Clincosm LogoSign in Get a demo

Diabetic Nephropathy

Showing 26 - 50 of 162
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

The Family Investigation of Nephropathy and Diabetes Study

Completed
  • Diabetes
  • Diabetic Nephropathy
    • Birmingham, Alabama
    • +4 more
    Apr 24, 2020

    Diabetes, Type 2, Diabetic Nephropathy Trial in Worldwide (Canagliflozin, Placebo)

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • Diabetic Nephropathy
    • Birmingham, Alabama
    • +592 more
    Dec 4, 2019

    Diabetic Nephropathy Trial in Taipei (acupressure by ankle band)

    Unknown status
    • Diabetic Nephropathy
    • acupressure by ankle band
    • Taipei, Taiwan
      Mackay Memerial Hospital
    Nov 21, 2019

    Diabetic Nephropathy Trial in United States (Repository Corticotropin Injection, Placebo)

    Completed
    Has Results
    • Diabetic Nephropathy
    • Repository Corticotropin Injection
    • Placebo
    • Roseville, California
    • +9 more
    Oct 31, 2019

    Type 2 Diabetes, Diabetic Nephropathy Trial in Xiamen (SGLT2 Inhibition)

    Unknown status
    • Type 2 Diabetes
    • Diabetic Nephropathy
    • SGLT2 Inhibition
    • Xiamen, Fujian, China
      Zhongshan Hospital Xiamen University
    Oct 16, 2019

    Diabetic Nephropathy Trial in Bulgaria, United States (Placebo, LY3016859)

    Completed
    Has Results
    • Diabetic Nephropathy
    • Clearwater, Florida
    • +6 more
    Sep 9, 2019

    Diabetic Kidney Disease, Diabetic Nephropathy, Diabetic Glomerulosclerosis Trial in Worldwide (LY2382770, Placebo)

    Terminated
    Has Results
    • Diabetic Kidney Disease
    • +2 more
    • Phoenix, Arizona
    • +77 more
    Sep 9, 2019

    Diabetic Nephropathy, Albuminuria Trial in Mexico City (Pirfenidone, Placebo)

    Unknown status
    • Diabetic Nephropathy
    • Albuminuria
    • Mexico City, Mexico
      Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubi
    Aug 6, 2019

    Diabetes, Diabetic Nephropathy Trial in United States (FG-3019)

    Completed
    • Diabetes Mellitus
    • Diabetic Nephropathy
    • Birmingham, Alabama
    • +17 more
    Jul 31, 2019

    Type 2 Diabetes, Diabetic Nephropathy Trial in Okayama (Intensive multifactorial therapy, Standard therapy)

    Completed
    • Type 2 Diabetes Mellitus
    • Diabetic Nephropathy
    • Intensive multifactorial therapy
    • Standard therapy
    • Okayama, Japan
      Okayama University Hospital
    Jul 19, 2019

    Diabetes, Type 2, Diabetic Nephropathy, Hypertension Trial in Singapore (Intensive)

    Recruiting
    • Diabetes Mellitus, Type 2
    • +2 more
    • Intensive
    • Singapore, Singapore
      Changi General Hospital
    May 5, 2019

    Diabetic Nephropathy Trial (Atrasentan, Placebo)

    Terminated
    Has Results
    • Diabetic Nephropathy
    • (no location specified)
    Mar 29, 2019

    Type 2 Diabetes, Diabetic Nephropathy, Diabetic Kidney Disease Trial in United States (FG-3019, Placebo)

    Terminated
    • Type 2 Diabetes Mellitus
    • +2 more
    • Tempe, Arizona
    • +27 more
    Feb 20, 2019

    Diabetic Nephropathy Trial in Chongqing (colchicine 0.5mg/d, 0.5mg/d)

    Active, not recruiting
    • Diabetic Nephropathy
    • colchicine 0.5mg/d
    • placebo 0.5mg/d
    • Chongqing, Chongqing, China
      The First Affiliated Hospital of Chongqing Medical University
    Jan 29, 2019

    Diabetic Nephropathy, Diabetic Retinopathy Trial in Worldwide (Spironolactone, Placebo, Standard care)

    Completed
    • Diabetic Nephropathy
    • Diabetic Retinopathy
    • Gent, Belgium
    • +14 more
    Dec 19, 2018

    Diabetic Nephropathy Trial in Kumamoto (CS-3150, )

    Completed
    • Diabetic Nephropathy
    • Kumamoto, Japan
      (unnamed)
    Dec 19, 2018

    Diabetic Nephropathy, Proteinuria, Oxidative Stress Trial in San Antonio (N-acetylcysteine and silibin , N-acetylcysteine

    Completed
    Has Results
    • Diabetic Nephropathy
    • +2 more
    • N-acetylcysteine placebo and silibin placebo
    • +4 more
    • San Antonio, Texas
      South Texas Health Care System, San Antonio, TX
    Sep 19, 2018

    Diabetic Nephropathy Trial (renal arterial resistive index, uric acid level, serum urea and creatinine)

    Unknown status
    • Diabetic Nephropathy
    • renal arterial resistive index
    • +7 more
    • (no location specified)
    Sep 12, 2018

    Type 1 Diabetes, Diabetic Nephropathy Trial in Gentofte (Allopurinol, Placebo)

    Completed
    • Type 1 Diabetes
    • Diabetic Nephropathy
    • Gentofte, Denmark
      Steno Diabetes Center
    Sep 6, 2018

    Type 2 Diabetes, Diabetic Nephropathy Trial in Gentofte (Dapagliflozine 10 mg once daily tablet treatment, Placebo identical

    Completed
    • Type 2 Diabetes
    • Diabetic Nephropathy
    • Dapagliflozine 10 mg once daily tablet treatment
    • Placebo identical once daily tablet treatment
    • Gentofte, Denmark
      Steno Diabetes Center
    Sep 6, 2018

    Chronic Kidney Disease, Diabetic Nephropathy Trial in Puerto Rico, United States (Placebo for Atrasentan 0.2 mg/mL solution,

    Completed
    • Chronic Kidney Disease
    • Diabetic Nephropathy
    • Placebo for Atrasentan 0.2 mg/mL solution
    • +3 more
    • Tempe, Arizona
    • +27 more
    Jun 1, 2018

    Diabetic Nephropathy Trial in Chicago, Melbourne, Groningen (Sulodexide, Placebo)

    Completed
    Has Results
    • Diabetic Nephropathy
    • Chicago, Illinois
    • +2 more
    Feb 22, 2018

    Diabetic Nephropathy Trial in Minneapolis (Lisinopril, Nifedipine, Simvastatin)

    Completed
    • Diabetic Nephropathy
    • Minneapolis, Minnesota
      Hennepin County Medical Center
    Mar 5, 2018

    Kidney Transplant, Diabetes, Type 2, Diabetic Nephropathy Trial in Stanford (Cyclosporin, Tacrolimus, 'Diabetes Education /

    Completed
    Has Results
    • Kidney Transplant
    • +2 more
    • Stanford, California
      Stanford university Hospital and Clinics
    Oct 4, 2017

    Diabetic Nephropathy Trial in Shiraz (Resveratrol, Placebo, Losartan)

    Completed
    • Diabetic Nephropathy
    • Shiraz, Fars, Iran, Islamic Republic of
      Shahid Motahhari Clinic, Shiraz University of Medical Sciences
    Oct 3, 2017